Advertisement
U.S. markets close in 2 hours 18 minutes
  • S&P 500

    4,563.49
    -31.14 (-0.68%)
     
  • Dow 30

    36,165.98
    -79.52 (-0.22%)
     
  • Nasdaq

    14,150.94
    -154.09 (-1.08%)
     
  • Russell 2000

    1,876.53
    +13.89 (+0.75%)
     
  • Crude Oil

    73.22
    -0.85 (-1.15%)
     
  • Gold

    2,043.30
    -46.40 (-2.22%)
     
  • Silver

    24.91
    -0.95 (-3.68%)
     
  • EUR/USD

    1.0821
    -0.0064 (-0.58%)
     
  • 10-Yr Bond

    4.2970
    +0.0710 (+1.68%)
     
  • GBP/USD

    1.2611
    -0.0102 (-0.81%)
     
  • USD/JPY

    147.4210
    +0.6600 (+0.45%)
     
  • Bitcoin USD

    41,713.09
    +2,123.84 (+5.36%)
     
  • CMC Crypto 200

    857.47
    -1.25 (-0.15%)
     
  • FTSE 100

    7,512.96
    -16.39 (-0.22%)
     
  • Nikkei 225

    33,231.27
    -200.24 (-0.60%)
     

Last Week's Biotech IPO Recap

Last week, eight biotech companies went public. Some of these companies traded much higher, while others traded lower.

Below is a recap of the IPOs from the week, and a look at how each performed on its first day of trading.

Zosano Pharma Corp (NASDAQ: ZSAN) offered 4.5 million shares on January 27 at $11. After the first day of trading, the stock closed at $11.01.

Ascendis Pharma A/S (NASDAQ: ASND) offered 6 million shares on January 28 at $18. After the first day of trading, the stock closed at $18.83.

Presbia PLC (NASDAQ: LENS) offered 4.2 million shares on January 29 at $10. After the first day of trading, the stock closed at $8.15.

Flex Pharma Inc (NASDAQ: FLKS) offered 5.4 million shares on January 29 at $16. After the first day of trading, the stock closed at $14.95.

Entellus Medical Inc (NASDAQ: ENTL) offered 4.6 million shares on January 29 at $17. After the first day of trading, the stock closed at $22.

TRACON Pharmaceuticals Inc (NASDAQ: TCON) offered 3.6 million shares on January 30 at $10. After the first day of trading, the stock closed at $9.40.

Spark Therapeutics Inc (NASDAQ: ONCE) offered 7 million shares on January 30 at $23. After the first day of trading, the stock closed at $50.

Avinger Inc (NASDAQ: AVGR) offered 5 million shares on January 30 at $14. After the first day of trading, the stock closed at $13.50.

See more from Benzinga

© 2015 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement